Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68

1.
2.

Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project.

Shantsila A, Dwivedi G, Shantsila E, Steeds RP, Beevers G, Lip GY.

Hypertens Res. 2012 Jul;35(7):725-8. doi: 10.1038/hr.2012.18.

PMID:
22357519
3.

Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial.

Robinson TG, Potter JF, Ford GA, Bulpitt CJ, Chernova J, Jagger C, James MA, Knight J, Markus HS, Mistri AK, Poulter NR; COSSACS Investigators..

Lancet Neurol. 2010 Aug;9(8):767-75. doi: 10.1016/S1474-4422(10)70163-0.

PMID:
20621562
4.

Revascularization versus medical therapy for renal-artery stenosis.

ASTRAL Investigators., Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J.

N Engl J Med. 2009 Nov 12;361(20):1953-62. doi: 10.1056/NEJMoa0905368.

5.

Beyond Texas City: the state of process safety in the unionized U.S. oil refining industry.

McQuiston TH, Lippin TM, Bradley-Bull K, Anderson J, Beach J, Beevers G, Frederick RJ, Frederick J, Greene T, Hoffman T, Lefton J, Nibarger K, Renner P, Ricks B, Seymour T, Taylor R, Wright M.

New Solut. 2009;19(3):271-88. doi: 10.2190/NS.19.3.a.

PMID:
19778828
6.

Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.

Olsen MH, Wachtell K, Beevers G, Dahlöf B, de Simone G, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Lyle PA, Nieminen MS, Omvik P, Oparil S, Wedel H.

J Hypertens. 2009 Mar;27(3):567-74. doi: 10.1097/HJH.0b013e32831daf96.

PMID:
19262226
7.

Calciphylaxis associated with widespread pulmonary calcification.

Dhanjal TS, Babu SB, Beevers G, Ferner RE.

BMJ Case Rep. 2009;2009. pii: bcr09.2008.0880. doi: 10.1136/bcr.09.2008.0880.

8.

Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention For End point reduction in hypertension (LIFE) study.

Olsen MH, Wachtell K, Beevers G, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Narayan P, Nieminen MS, Omvik P, Oparil S, Wedel H.

Am Heart J. 2009 Jan;157(1):177-84. doi: 10.1016/j.ahj.2008.08.011.

PMID:
19081416
9.

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.

Ostergren J, Poulter NR, Sever PS, Dahlöf B, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E; ASCOT investigators..

J Hypertens. 2008 Nov;26(11):2103-11. doi: 10.1097/HJH.0b013e328310e0d9.

PMID:
18854748
10.

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

ADVANCE Collaborative Group., Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F.

N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987.

11.

The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure.

Sever PS, Poulter NR, Dahlof B, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes G, Mehlsen J, Nieminen MS, O'Brien ET, Ostergren J; ASCOT Investigators..

Eur Heart J. 2008 Feb;29(4):499-508. doi: 10.1093/eurheartj/ehm583.

PMID:
18175773
12.
13.

Diuretics for preventing pre-eclampsia.

Churchill D, Beevers GD, Meher S, Rhodes C.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004451. Review.

PMID:
17253507
14.

Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial.

Sever P, Dahlöf B, Poulter N, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen S, Kristinsson A, McInnes G, Mehlsen J, Nieminem M, O'Brien E, Ostergren J; ASCOT Steering Committee Members..

Eur Heart J. 2006 Dec;27(24):2982-8. Erratum in: Eur Heart J. 2007 Jan;28(1):142.

PMID:
17145722
15.

Clinical trials in hypertension.

Messerli FH, Beevers G, Franklin SS, Pickering TG.

JAMA. 2006 Sep 27;296(12):1463; author reply 1464-5. No abstract available.

PMID:
17003392
16.

Quantification of topological changes in retinal vascular architecture in essential and malignant hypertension.

Hughes AD, Martinez-Perez E, Jabbar AS, Hassan A, Witt NW, Mistry PD, Chapman N, Stanton AV, Beevers G, Pedrinelli R, Parker KH, Thom SA.

J Hypertens. 2006 May;24(5):889-94.

PMID:
16612251
17.

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

Sever PS, Poulter NR, Dahlöf B, Wedel H, Collins R, Beevers G, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J.

Diabetes Care. 2005 May;28(5):1151-7.

PMID:
15855581
18.

Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.

de Simone G, Wachtell K, Palmieri V, Hille DA, Beevers G, Dahlöf B, de Faire U, Fyhrquist F, Ibsen H, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Devereux RB.

Circulation. 2005 Apr 19;111(15):1924-31.

19.

Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension.

Karalis I, Beevers G, Beevers M, Lip G.

Blood Press. 2005;14(1):38-44.

PMID:
15823946
20.

Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.

Fyhrquist F, Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Hille DA, Lyle PA, Edelman JM, Snapinn SM, Wedel H; LIFE Study Group..

Hypertension. 2005 Apr;45(4):580-5.

Supplemental Content

Loading ...
Support Center